Autolus Therapeutics Recognized with 2026 Prix Galien UK Award for Best Biotechnology Product

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-12T08:10:00Z
Category: business
Source: Quiver Quantitative
Original source

Autolus Therapeutics plc, a biopharmaceutical company focused on next-generation programmed T cell therapies, was awarded the 2026 Prix Galien UK Award for Best Biotechnology Product by the Galien Foundation. This recognition highlights the company's commitment to translating scientific research into treatment options for patients with cancer and autoimmune diseases.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai